Stock listing

Frankfurt:7F0 Fulgent Genetics, Inc. Aktie

German listing (Frankfurt) of Fulgent Genetics, Inc. · home listing NASDAQ:FLGT

Follow Fulgent Genetics, Inc. into a list and get an email when it puts out news.

Share price · FWB:7F0

€19.10 EUR +1.10 (+6.1%)

Close on Oct 30, 2026

Day range
€19.10 – €19.10 EUROct 30, 2026
Market cap
€525.5M EURAt the close on Oct 30, 2026 · price × 27.52M shares outstanding
Fulgent Genetics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FLGT · Home$20.62 USD-1.06 (-4.9%)201,368$21.50$21.50$20.55$21.68Close on Oct 30, 2026
Frankfurt:7F0€19.10 EUR+1.10 (+6.1%)—€19.10€19.10€19.10€18.00Close on Oct 30, 2026
Ticker
Frankfurt:7F0
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Upcoming

  • Fulgent Genetics (NASDAQ:FLGT) Q3 2026 Earnings Call

    Thu, Nov 05, 2026 · 4:30 PM ET

    Register

Replays

  • Fulgent Genetics (NASDAQ:FLGT) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 4:30 PM ET

    Watch Transcript

  • Fulgent Genetics (NASDAQ:FLGT) Q1 2026 Earnings Call

    Fri, May 01, 2026 · 8:30 AM ET

    Watch Transcript

  • Fulgent Genetics (NASDAQ:FLGT) Q4 2025 Earnings Call

    Fri, Feb 27, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026

Oct 15, 2026

Fulgent Reports Second Quarter 2026 Financial Results

Jul 30, 2026

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Jul 9, 2026

Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture

Jun 18, 2026

Fulgent Presents Updated FID-007 Data at ASCO 2026

Jun 1, 2026

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting

May 21, 2026

Fulgent Reports First Quarter 2026 Financial Results

May 1, 2026

Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting

Apr 22, 2026

Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026

Apr 16, 2026

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Mar 17, 2026

All Fulgent Genetics, Inc. news

Decks

Fulgent Genetics, Inc. on 6ix

News releases
15 in the last 12 months · 127 in all · newest Oct 15, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Jul 30, 2026
Decks
23 decks · latest Jul 30, 2026

Where Fulgent Genetics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FLGT · Home listingNASDAQUnited StatesUSD
LS Exchange:A2AS4NLS ExchangeGermanyEUR
Lang & Schwarz:A2AS4NLang & SchwarzGermanyEUR
BMV:FLGTBMVMexicoMXN
BIVA:FLGTBIVAMexicoMXN
gettex:7F0gettexGermanyEUR
BOATS:FLGTBOATSUnited StatesUSD
Frankfurt:7F0 · This pageFrankfurtGermanyEUR
Dusseldorf:7F0DusseldorfGermanyEUR
Munich:7F0MunichGermanyEUR
Stuttgart:7F0StuttgartGermanyEUR
Tradegate:7F0TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Fulgent Genetics, Inc.